Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer
Laetitia Fend(Transgene (France)), Laurence Zitvogel(Inserm), Isabelle Cremer(Inserm), Sylvie Rusakiewicz(Inserm), Michaëla Semeraro(Inserm), Christina Iribarren(Délégation Paris 5), Meriem Messaoudene(Centre Hospitalier de l’Université de Montréal), Aurélien Marabelle(Université Paris-Saclay), Jean‐Marc Limacher(Transgene (France)), Guido Kroemer(Inserm), Anne Caignard(Inserm), Bérangère Bastien(Transgene (France)), Christophe Borg(Inserm), Alexander Eggermont(University Medical Center Utrecht), Luc Barraud(Transgene (France)), Julien Adam(Institut Gustave Roussy)
Cited by 39
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
|Cell Death and Differentiation|2008|3.3k
The molecular machinery of regulated cell death
|Cell Research|2019|2.5k
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
|Cell Death and Differentiation|2011|2.4k
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
|The Journal of Experimental Medicine|2005|1.5k